These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6426105)
1. The role of anti-tumor antibody in progressive tumor growth. Manson LA Transplant Proc; 1984 Apr; 16(2):524-7. PubMed ID: 6426105 [No Abstract] [Full Text] [Related]
2. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958 [TBL] [Abstract][Full Text] [Related]
3. Quantitative approaches to the assessment of cell-mediated immune responses to solid tumor allografts. MacDonald HR; Lees RK; Howell RL Transplant Proc; 1978 Jun; 10(2):339-42. PubMed ID: 97826 [No Abstract] [Full Text] [Related]
4. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice. Jose DG; Good RA Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154 [No Abstract] [Full Text] [Related]
5. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor. Biddison WE; Palmer JC; Alexander MA; Cowan EP; Manson LA J Immunol; 1977 Jun; 118(6):2243-53. PubMed ID: 68083 [No Abstract] [Full Text] [Related]
6. The use of allogeneic stimulation and exogenous interleukin for syngeneic tumor rejection. Sherburne CG; Condie RM; Nnadi EC; Adlin M Transplant Proc; 1987 Feb; 19(1 Pt 1):628-31. PubMed ID: 3493564 [TBL] [Abstract][Full Text] [Related]
7. Combined effect of X irradiation and cell-mediated immune reaction. Song CW; Guertin DP Radiat Res; 1978 Sep; 75(3):586-92. PubMed ID: 103127 [No Abstract] [Full Text] [Related]
8. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Townsend SE; Su FW; Atherton JM; Allison JP Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298 [TBL] [Abstract][Full Text] [Related]
9. [Activation of the membrane toxicity and cytotoxicity of the tumor cell by leukocyte and fibroblast interferon]. Sterlina AG; Malinovskaia VV; Bogdashin IV; Fuks BB Biull Eksp Biol Med; 1982 Dec; 94(12):80-2. PubMed ID: 7150772 [TBL] [Abstract][Full Text] [Related]
10. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target. Al-Rammahy AK; Levy JG Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763 [No Abstract] [Full Text] [Related]
11. Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors. Liu B; Podack ER; Allison JP; Malek TR J Immunol; 1996 Feb; 156(3):1117-25. PubMed ID: 8557987 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines. Fuji H Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299 [TBL] [Abstract][Full Text] [Related]
13. [Anti-Titin-antibodies at the patients with myasthenic and non-myasthenic thymoma]. Vetshev PS; Sanadze AG; Sidnev DV; Ippolitov LI; Zhivotov VA; Ablitsov AIu Khirurgiia (Mosk); 2007; (6):53-6. PubMed ID: 17690667 [TBL] [Abstract][Full Text] [Related]
14. Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines. Salem ML Int Immunopharmacol; 2005 Jun; 5(6):947-60. PubMed ID: 15829411 [TBL] [Abstract][Full Text] [Related]
15. Immunologic and virologic properties of chemically and gamma-irradiation-induced thymic lymphomas in mice. Chan PL; Sinclair NR J Natl Cancer Inst; 1972 Jun; 48(6):1629-40. PubMed ID: 5066471 [No Abstract] [Full Text] [Related]
16. Hypogammaglobulinaemia with thymoma. Mallinson WJ; Beck ER Proc R Soc Med; 1971 Dec; 64(12):1305-6. PubMed ID: 5131297 [No Abstract] [Full Text] [Related]
17. [Cytochalasin B is an inhibitor of the cytotoxic activity of sensitized lymphoid cells]. Degiovanni G C R Seances Soc Biol Fil; 1972; 166(4):736-40. PubMed ID: 4631303 [No Abstract] [Full Text] [Related]
18. Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells. Balk SP; Mescher MF J Immunol; 1981 Jul; 127(1):51-7. PubMed ID: 6787131 [TBL] [Abstract][Full Text] [Related]
19. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754 [TBL] [Abstract][Full Text] [Related]
20. [Immunoregulatory effect of polysaccharide of Acanthopanax senticosus (PAS). I. Immunological mechanism of PAS against cancer]. Xie SS Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):338-40. PubMed ID: 2620627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]